Actively Recruiting
Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers
Led by University Hospital, Strasbourg, France · Updated on 2025-08-03
48
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to check the role of the cerebellum in time prediction in healthy volunteers, by means of magnetic transcranial stimulation targeted on the cerebellum, and recording of behavioural measures indexing time prediction
CONDITIONS
Official Title
Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant, male or female, between 18 and 60 years old
- Subject affiliated to a social health insurance scheme (beneficiary or entitled person)
- Subject who has dated and signed an informed consent form
- For a woman of childbearing age, negative pregnancy test and effective contraception throughout the study
You will not qualify if you...
- Participant with substance use disorders as defined by DSM-V
- Participants using benzodiazepines and related substances (within 5 half-lives before inclusion), cannabis (in the 2 months before inclusion), or hallucinogenic substances (within 5 half-lives before inclusion)
- Participant with neurological pathology or sequelae
- Participant with Attention Deficit Hyperactivity Disorder (ADHD)
- Participant with borderline personality disorder
- Participant with disabling sensory impairments, including visual acuity (corrected if applicable) less than 0.8
- Participant deprived of liberty or subject to the safeguard of justice
- Participant under guardianship or curatorship
- Participant currently involved in another clinical study that may affect results
- Pregnant or breastfeeding woman
- Subject with contraindications to MRI or TMS such as non-removable ferromagnetic body, prosthesis, pacemaker, implanted pump medication, vascular clip or stent, heart valve or ventricular lead, certain intracerebral clips, cochlear implants, history of epilepsy, or skin pathology at electrode contact points
- Subject with a history of major neurological or psychiatric illness currently treated with psychotropic medication such as antidepressants, thyroid regulators, antipsychotics, benzodiazepines, or hypnotics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Strasbourg
Strasbourg, France
Actively Recruiting
Research Team
A
Anne Giersch
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here